Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor

Nephrology Dialysis Transplantation

Volumn 19, Issue 11, 2004, Pages 2831-2837

  Ogata, Satoshi ^a   Naito, Takayuki ^a,b   Yorioka, Nariaki ^b   Kiribayashi, Kei ^b   Kuratsune, Masatoshi ^b   Kohno, Nobuoki ^b  

^a National Hospital Organization   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Fibrosis; Growth factors; Peritoneal dialysis; Vascular reactivity

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BICARBONATE; LACTIC ACID; NEUTRALIZING ANTIBODY; RECOMBINANT FIBROBLAST GROWTH FACTOR; TETRAZOLIUM;

ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL ASSAY; CELL CULTURE; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; ENDOTHELIUM CELL; FIBROBLAST; FIBROSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MESOTHELIUM CELL; MITOCHONDRION; NEOVASCULARIZATION (PATHOLOGY); PERITONEAL DISEASE; PERITONEUM CELL; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BICARBONATES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DIALYSIS SOLUTIONS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FIBROSIS; HUMANS; LACTIC ACID; MITOCHONDRIA; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL CAVITY; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; TETRAZOLIUM SALTS; UMBILICAL VEINS;

EID: 8344234994     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh478     Document Type: Article

References (20)

1. Mateijsen MA, van der Wal AC, Hendriks PM et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-525
2. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
3. Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 2003; 23: 116-122
4. Topley N, Kaur D, Petersen MM et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996, 49: 1447-1456
5. Devuyst O. New insights in the molecular mechanisms regulating peritoneal permeability. Nephrol Dial Transplant 2002; 17: 548-551
6. Inagi R, Miyata T, Yamamoto T et al. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999; 463: 260-264
7. Mlambo NC, Hylander B, Brauner A. Increased levels of transforming growth factor β1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis. Inflammation 1999; 23: 131-139
8. Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51: 205-215
9. Ogata S, Yorioka N, Kohno N. Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts. J Am Soc Nephrol 2001; 12: 2787-2796
10. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-1570
11. Plum J, Razeghi P, Lordnejad RM et al. Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer - effects on human mesothelial cells. Am J Kidney Dis 2001; 38: 867-875
12. Cronauer MV, Stadlmann S, Klocker H et al. Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol 1999; 155: 1977-1984
13. De Vriese AS, Tilton RG, Stephan CC, Lameire NH. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12: 1734-1741
14. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001; 12: 1448-1457
15. Fukasawa M, Campeau JD, Yanagihara DL, Rodgers KE, di Zerega GS. Regulation of proliferation of peritoneal tissue repair cells by peritoneal macrophages. J Surg Res 1990; 49: 81-87
16. Feriani M, Carobi C, Greca GL, Buoncristiani U, Passlick-Deeetjen J. Clinical experience with a 39 mmol/l bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 1997; 17: 17-21
17. Feriani M, Kirchgessner J, Greca GL, Passlick-Deetjen J, and the Bicarbonate CAPD Cooperative Group. Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 1998; 54: 1731-1738
18. Zeier M, Schwenger V, Deppisch R et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63: 298-305
19. Liberek T, Topley N, Jorres A et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65: 260-265
20. Plum J, Fleisch MC, Razeghi P et al. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells. Kidney Blood Press Res 2002; 25: 195-201